Testing effectiveness (Phase 2)Study completedNCT02918318
What this trial is testing
Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
Who this might be right for
Depression
Janssen Pharmaceutical K.K. 202